Immunization with specific polysaccharide antigen reduces alterations in corneal proteoglycans during experimental slime-producing Staphylococcus epidermidis keratitis

Current Eye Research

Volumn 31, Issue 2, 2006, Pages 137-146

  Georgakopoulos, C ^a   Exarchou, A ^a   Gartaganis, S ^a,c   Kolonitsiou, F ^a   Anastassiou, E ^a   Dimitracopoulos, G ^a   Hjerpe, A ^b   Theocharis, A ^a   Karamanos, N ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Experimental keratitis; Extracellular matrix; Immunization; Slime; Staphylococcus epidermidis

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; DECORIN; HEPARAN SULFATE; KERATAN SULFATE; POLYSACCHARIDE ANTIBODY; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; AQUEOUS HUMOR; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA INJURY; CORNEA STROMA; CORNEA VASCULARIZATION; DRUG EFFICACY; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; KERATITIS; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; WOUND HEALING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; AQUEOUS HUMOR; CORNEA; CORNEAL ULCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, BACTERIAL; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MOLECULAR WEIGHT; POLYSACCHARIDES, BACTERIAL; PROTEOGLYCANS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VACCINATION;

EID: 33644633726     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680500516540     Document Type: Article

References (44)

1. Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834-838.
2. Nayak N, Satpathy G. Slime production as a virulence factor in Staphylococcus epidermidis isolated from bacterial keratitis. Indian J Med Res. 2000;111:6-10.
3. Nayak N, Satpathy G, Vajpayee R, et al. Clinical significance of slime production by Staphylococcus epidermidis in bacterial keratitis. Ann Ophthalmol. 2002;34:204-210.
4. Boussard P, Pithsy A, Devleeschouwer MJ. Relationship between slime production, antibiotic sensitivity and the phagetype of coagulase-negative staphylococci. J Clin Pharm Ther. 1993;18:271-274.
5. Kotilainen P, Nikoskelainen J, Huovinen P. Antibiotic susceptibility of coagulase-negative staphylococcal blood isolates with special reference to adherent, slime-producing Staphylococcus epidermidis strains. Scand J Infect Dis. 1991;23:325-332.
6. Gristina AG, Jennings RA, Naylor PT, et al. Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. Antimicrob Agents Chemother. 1989;33:813-816.
7. Younger JJ, Christensen GD, Bartley DL, et al. Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis. 1987;156:548-554.
8. Heilmann C, Hussain M, Peters G, Götz F. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol. 1997;24:1013-1024.
9. McKenney D, Hübner J, Muller E, et al. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesion. Infect Immun. 1998;66:4711-4720.
10. Nilsson M, Frykberg L, Flock JI, et al. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun. 1998;66:2666-2673.
11. Tojo M, Yamashita N, Goldmann DA, Pier GB. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis. 1988;157:713-722.
12. Veenstra GJ, Cremers FF, van Dijk H, Fleer A. Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol. 1996;178:537-541.
13. Mack D, Fischer W, Krokotsch A, et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear β-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol. 1996;178:175-183.
14. Mack D, Nedelmann M, Krokotsch A, et al. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun. 1994;62:3244-3253.
15. Arvaniti A, Karamanos NK, Dimitracopoulos G, Anastassiou ED. Isolation and characterization of a novel 20-kDa sulfated polysaccharide from the extracellular slime layer of Staphylococcus epidermidis. Arch Biochem Biophys. 1994;308:432-438.
16. Karamanos NK, Panagiotopoulou HS, Syrokou A, et al. Identity of macromolecules present in the extracellular slime layer of Staphylococcus epidermidis. Biochimie. 1995;77:217-224
17. Karamanos NK, Syrokou A, Panagiotopoulou HS, et al. The major 20-kDa polysaccharide of Staphylococcus epidermidis extracellular slime and its antibodies as powerful agents for detecting antibodies in blood serum and differentiating among slime-positive and -negative S. epidermidis and other staphylococci species. Arch Biochem Biophys. 1997;342:389-395.
18. Kolonitsiou F, Syrokou A, Karamanos NK, et al. Immunoreactivity of 80-kDa peptidoglycan and teichoic acid-like substance of slime producing 5. epidermidis and specificity of their antibodies studied by an enzyme immunoassay. J Pharm Biomed Anal. 2001;24:429-436.
19. Lamari F, Karamanos NK, Papadopoulou-Alataki E, et al. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients. J Pharm Biomed Anal. 2000;22:1029-1036.
20. Lamari F, Anastassiou E.D, Stamokosta E, et al. Determination of slime-producing S. epidermidis specific antibodies in human immunoglobulin preparations and blood sera by an enzyme immunoassay: correlation of antibody titers with opsonic activity and application to preterm neonates. J Pharm Biomed Anal. 2000;23:363-374.
21. Georgakopoulos CD, Exarchou A, Koliopoulos JX, et al. Levels of specific antibodies towards the major antigenic determinant of slime-producing Staphylococcus epidermidis determined by an enzyme immunoassay and their protective effect in experimental keratitis. J Pharm Biomed Anal. 2002;29:255-262.
22. Maurice DM. The structure and transparency of the cornea. J Physiol. 1957;136:263-286.
23. Bettelheim FA, Plessy B. The hydration of proteoglycans of bovine cornea. Biochim Biophys Acta. 1975;381:203-214.
24. Scott JE, Bosworth TR. A comparative biochemical and ultrastructural study of proteoglycan-collagen interaction in corneal stroma. Biochem J. 1990;270:491-497.
25. Weber IT, Harrison RW, Iozzo RV. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem. 1996;271:31767-31770.
26. Scott JE. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry. 1996;35:8795-8799.
27. Saika S, Shiraishi A, Liu CY, et al. Role of lumican in the corneal epithelium during wound healing. J Biol Chem. 2000;275:2607-2612.
28. Preston MJ, Gerceker AA, Koles NL, et al. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Invest Ophthalmol Vis Sci. 1997;38:1418-1425.
29. Schmidt R, Wirtala J. Modification of movat pentachrome stain with improved reliability of elastin staining. J Histotechnol. 1996;19:325-327.
30. Elder MJ, Stapleton F, Evans E, Dart JK. Biofilm-related infections in ophthalmology. Eye. 1995;9:102-109.
31. Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis. 1994;19:231-243.
32. O'Gara JP, Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol. 2001;50:582-587.
33. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 1998;26:1182-1187.
34. Preston MJ, Kernacki KA, Berk JM, et al. Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa. Infect Immun. 1992;60:885-891.
35. Schwarz W, Keyserlingk DG. Electron microscopic studies of human corneal scars and of an opaque corneal transplant. Virchows Arch A Pathol Pathol Anat. 1969;347:115-128
36. Cintron C, Hassinger LC, Kublin CL, Cannon DJ. Biochemical and ultrastructural changes in collagen during corneal wound healing. J Ultrastruct Res. 1978;65:13-22.
37. Hassell JR, Cintron C, Kublin C, Newsome DA. Proteoglycan changes during restoration of transparency in corneal scars. Arch Biochem Biophys. 1983;222:362-369.
38. Funderburgh JL, Cintron C, Covington HI, Conrad GW. Immunoanalysis of keratan sulfate proteoglycan from corneal scars. Invest Ophthalmol Vis Sci. 1988;29:1116-1124.
39. Funderburgh JL, Chandler JW. Proteoglycans of rabbit corneas with nonperforating wound. Invest Ophthalmol Vis Sci. 1989;30:435-442.
40. Brown CT, Applebaum E, Banwatt R, Trinkaus-Randall V. Synthesis of stromal glycosaminoglycans in response to injury. J Cell Biochem. 1995;59:57-68.
41. Cintron C, Gregory JD, Damle SP, Kublin CL. Biochemical analyses of proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci. 1990;31:1975-1981.
42. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;41:2514-2522.
43. Soubrane G, Jerdan J, Karpouzas I, et al. Binding of basic fibroblast growth factor to normal and neovascularized rabbit cornea. Invest Ophthalmol Vis Sci. 1990;31:323-333.
44. Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell. 1995;83:357-360.